Randomized controlled trial comparing radiotherapy plus /- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG0401

被引：0

作者：

Yokomizo, A. ^{[1
]}

Satoh, T. ^{[2
]}

Hashine, K. ^{[3
]}

Inoue, T. ^{[4
]}

Fujimoto, K. ^{[5
]}

Egawa, S. ^{[6
]}

Habuchi, T. ^{[7
]}

Kawashima, K. ^{[8
]}

Ishizuka, O. ^{[9
]}

Shinohara, N. ^{[10
]}

Sugimoto, M. ^{[11
]}

Yoshino, Y. ^{[12
]}

Wakabayashi, M. ^{[13
]}

Nihei, K. ^{[14
]}

Fukuda, H. ^{[13
]}

Tobisu, K-I. ^{[15
]}

Kakehi, Y.

Naito, S. ^{[1
]}

机构：

[1] Harasanshin Hosp, Urol, Fukuoka, Japan

[2] Kitasato Univ, Urol, Sch Med, Sagamihara, Kanagawa, Japan

[3] Natl Hosp Org, Urol, Shikoku Canc Ctr, Matsuyama, Ehime, Japan

[4] Kyoto Univ, Urol, Kyoto, Japan

[5] Nara Med Univ, Urol, Nara, Japan

[6] Jikei Univ Hosp, Urol, Tokyo, Japan

[7] Akita Univ, Urol, Grad Sch Med, Akita, Japan

[8] Tochigi Canc Ctr, Urol, Utsunomiya, Tochigi, Japan

[9] Shinshu Univ, Urol, Sch Med, Matsumoto, Japan

[10] Hokkaido Univ Hosp, Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan

[11] Kagawa Univ, Urol, Fac Med, Takamatsu, Kagawa, Japan

[12] Nagoya Univ, Urol, Grad Sch Med, Nagoya, Aichi, Japan

[13] Natl Canc Ctr, JCOG Data Ctr, Operat Off, Tokyo, Japan

[14] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Radiat Oncol, Tokyo, Japan

[15] Komagome Hosp, Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

788PD

引用

页数：2

共 50 条

[41] A RANDOMIZED TRIAL (IRISH CLINICAL ONCOLOGY RESEARCH GROUP 97-01) COMPARING SHORT VERSUS PROTRACTED NEOADJUVANT HORMONAL THERAPY BEFORE RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER
Armstrong, John G.
Gillham, Charles M.
Dunne, Mary T.
Fitzpatrick, David A.
Finn, Marie A.
Cannon, Mairin E.
Taylor, Judy C.
O'Shea, Carmel M.
Buckney, Steven J.
Thirion, Pierre G.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 35 - 45
[42] Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)’
N Katsumata
British Journal of Cancer, 2013, 109 : 2506 - 2506
[43] Reply: 'Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'
Katsumata, N.
BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2506 - 2506
[44] Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy:: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer?: First results of International Breast Cancer Study Group Trial 11-93
Thürlimann, B
Price, KN
Castiglione, M
Coates, AS
Goldhirsch, A
Gelber, RD
Forbes, J
Holmberg, S
Veronesi, A
Bernhard, J
Zahrieh, D
BREAST, 2001, 10 : 130 - 138
[45] A Randomized Phase II/III Trial of Perioperative Chemotherapy with Adriamycin Plus Ifosfamide Versus Gemcitabine Plus Docetaxel for High-grade Soft Tissue Sarcoma: Japan Clinical Oncology Group Study JCOG1306
Kataoka, Kozo
Tanaka, Kazuhiro
Mizusawa, Junki
Kimura, Aya
Hiraga, Hiroaki
Kawai, Akira
Matsunobu, Tomoya
Matsumine, Akihiko
Araki, Nobuhito
Oda, Yoshinao
Fukuda, Haruhiko
Iwamoto, Yukihide
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (08) : 765 - 769
[46] A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603
Kanemitsu, Yukihide
Kato, Tomoyuki
Shimizu, Yasuhiro
Inaba, Yoshitaka
Shimada, Yasuhiro
Nakamura, Kenichi
Sato, Akihiro
Moriya, Yoshihiro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (06) : 406 - 409
[47] Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)
Kita, Ryosuke
Matsuda, Satoru
Nomura, Motoo
Machida, Ryunosuke
Sasaki, Keita
Kato, Ken
Goto, Rei
Yoshioka, Takashi
Yamamoto, Shun
Tsushima, Takahiro
Fukuda, Haruhiko
Takeuchi, Hiroya
Kitagawa, Yuko
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (02) : 212 - 216
[48] A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study)
Ohue, Masayuki
Iwasa, Satoru
Kanemitsu, Yukihide
Hamaguchi, Tetsuya
Shiozawa, Manabu
Ito, Masaaki
Yasui, Masayoshi
Katayama, Hiroshi
Mizusawa, Junki
Shimada, Yasuhiro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 84 - 87
[49] A randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colon cancer: Primary analysis of Japan Clinical Oncology Group study JCOG1006.
Takii, Yasumasa
Mizusawa, Junki
Kanemitsu, Yukihide
Komori, Koji
Shiozawa, Manabu
Ohue, Masayuki
Nishimura, Yoji
Ikeda, Satoshi
Takiguchi, Nobuhiro
Kobatake, Takaya
Ike, Hideyuki
Sato, Toshihiko
Tomita, Naohiro
Ota, Mitsuyoshi
Masaki, Tadahiko
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[50] Transitional impact of short and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404
Fujii, S.
Inomata, M.
Akagi, T.
Katayama, H.
Mizusawa, J.
Saito, S.
Saida, Y.
Munakata, Y.
Sato, T.
Bandou, H.
Sekimoto, M.
Yamamoto, H.
Shimada, Y.
Kitano, S.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S139 - S139

← 1 2 3 4 5 →